Meet an Unreasonable Venture
Roceso
Enhancing quality of life through neurorehabilitation, anytime and anywhere.
Roceso Technologies specialises in developing robotic rehabilitation devices and digital health solutions for neurological recovery. The company provides services for conditions like stroke and cerebral palsy, offering solutions for both clinical settings and at-home use. Roceso was established in 2016 and operates in over 30 countries. Their aim is to revolutionise neurorehabilitation with AI-driven, personalised therapy solutions for various body parts, expanding their reach to countries worldwide.
Notable Achievements
- CygniCONNECT platform enables remote monitoring and therapy, distinguishing it from competitors by enhancing accessibility and continuity of
- Unlike rigid systems, Roceso's soft robotics mimic natural muscle movement, offering a more effective and comfortable rehabilitation experie
- Expanded its global footprint to 30+ countries.
Currently Operating in 15 Regions
Press Mentions
May 23, 2024
Unreasonable Impact announces new roster of ventures for Asia Pacific programme
Singapore, Friday 24 May 2024: Unreasonable Impact, a strategic partnership between Unreasonable Group and Barclays, has announced the latest ventures to join its Asia Pacific programme. This...
Read on Unreasonable »More Ventures in Health
Get the Unreasonable Newsletter
Get monthly updates on Roceso and over 398 other ventures working to solve the world's toughest problems.